Skip to main content

Closed

GERN: Geron Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+32386.9% / yr

Operating margin-19.1%

ROIC-7.8%

Financially safe

Stretched

Debt / equity1.10×

Interest coverage-1.2×

Current ratio6.78×

Geron Corporation

GERNNASDAQ Global Select·USD·Closed

Geron Corporation

GERNNASDAQ·USD·Closed

$1.29

−3.73%

$1.29

−$0.05 (3.73%)

52W Range

26thpctl

Volume

1.54×avg

Mkt Cap

827.56MUSD

P/E

-12.4TTM

Div Yield

–ann

52W Range

26thpctl

Volume

1.54×avg

Market Cap

827.56MUSD

P/E Ratio

-12.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings